key: cord-0850358-gf0sngit
authors: Nava-Muñoz, Á.; Gómez-Peña, S.; Fuentes-Ferrer, M.E.; Cabeza, B.; Victoria, A.; Bustos, A.
title: COVID-19 pneumonia: relationship between initial chest X-rays and laboratory findings()
date: 2021-10-27
journal: Radiologia (Engl Ed)
DOI: 10.1016/j.rxeng.2021.06.003
sha: 39e57f76f718c25df308f7338a8aa07ac11919db
doc_id: 850358
cord_uid: gf0sngit

OBJECTIVE: To analyze the initial findings in chest X-rays of patients with RT-PCR positive for SARS-CoV-2, and to determine whether there is a relationship between the severity of these findings and the clinical and laboratory findings. MATERIALS AND METHODS: This retrospective study analyzed the relationship between initial chest X-rays and initial laboratory tests in symptomatic adults with nasopharyngeal RT-PCR results positive for SARS-CoV-2 seen at our center between February 29 and March 23, 2020. Among other radiologic findings, we analyzed ground-glass opacities, consolidations, linear opacities, and pleural effusion. We also used a scale of radiologic severity to assess the distribution and extent of these findings. Among initial laboratory findings, we analyzed leukocytes, lymphocytes, platelets, neutrophil-to-lymphocyte ratio, and C-reactive protein. RESULTS: Of 761 symptomatic patients, 639 (84%) required hospitalization and 122 were discharged to their homes. The need for admission increased with increasing scores on the scale of radiologic severity. The extent of initial lung involvement was significantly associated with the laboratory parameters analyzed (p < 0.05 for platelets, p < 0.01 for lymphocytes, and p < 0.001 for the remaining parameters), as well as with the time from the onset of symptoms (p < 0.001). CONCLUSION: It can be useful to use a scale of radiologic severity to classify chest X-ray findings in diagnosing patients with COVID-19, because the greater the radiologic severity, the greater the need for hospitalization and the greater the alteration in laboratory parameters.

On 31 December 2019, a number of cases of a form of pneumonia of unknown aetiology detected in Wuhan, China, were reported to the World Health Organization (WHO). The causative agent of this pneumonia was identified as a novel virus belonging to the family Coronaviridae; it was subsequently named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). The disease associated with this virus was has been termed COVID-19 (COrona VIrus Disease-2019). The WHO declared COVID-19 a public health emergency of international concern on 30 January 2020 and a pandemic on 12 March 2020. 1, 2 To date (18 December 2020), 1,797,236 confirmed cases and 48,926 deaths have been reported in Spain. 3 The clinical spectrum of COVID-19 ranges from asymptomatic forms to severe forms with adult respiratory distress syndrome and death. The most commonly reported clinical signs are fever, cough, muscle pain, headache and shortness of breath. 4 Severe or fatal disease is more common in admitted patients. 5 Most initial radiology publications on COVID-19 focused on findings in computed tomography (CT) of the chest, since China started using this technique as a first-line option given its high sensitivity. 6 The American College of Radiology (ACR), the Society of Thoracic Radiology (STR) and American Society of Emergency Radiology (ASER) subsequently discouraged systematic use of CT of the chest as a screening technique or as a first-line option in the diagnosis of patients with suspected COVID-19. 7 A meta-analysis by Kim et al. confirmed that, outside of China, where there is a low prevalence of COVID-19 (1%-22.9%), CT of the chest in patients with clinically suspected COVID-19 had a low positive predictive value (1.5%-30.7%). 8 In another more recent metaanalysis, Xu et al. concluded that, in general, CT of the chest had good sensitivity for detecting COVID-19 pneumonia, especially in regions with severe outbreaks, and it was useful for detecting suspicious cases in early stages. Its sensitivity, on the other hand, was relatively low (25%-33%). 9 Chest X-ray is less sensitive than CT and therefore may be normal in early stages of COVID-19, but it is a useful, fast, widely available and easy-to-perform technique. In most cases, it has been the only diagnostic imaging technique performed in these patients. 7 However, chest X-ray has wide interobserver variability. To attempt to mitigate this variability, different objective methods of assessing the extent and severity of lung involvement have been used. For example, the Radiographic Assessment of Lung Edema (RALE) score was useful for measuring the extent of adult respiratory distress syndrome. 10 More recently, different scoring systems, both for CT and for chest X-ray, that measure lung involvement in patients with COVID-19 have also been used. [11] [12] [13] [14] [15] [16] To date, very few studies linking measurements of severity of chest X-ray findings to laboratory findings have been published. 12, 17 The main laboratory findings that have linked the severity of COVID-19 pneumonia and the clinical course of patients have been increased C-reactive protein (CRP), increased D-dimer, increased lactate dehydrogenase (LDH) and lymphopenia. 18 The objective of this study was to determine whether there is a relationship between, on the one hand, findings on chest X-ray and measurement of their severity and, on the other hand, laboratory findings at the time of diagnosis and time elapsed since the onset of symptoms.

J o u r n a l P r e -p r o o f Material and methods A descriptive, cross-sectional, retrospective, single-centre study was conducted. This study was approved by the Independent Ethics Committee at our hospital.

Symptomatic adult patients seen at our hospital between 29 February and 23 March 2020, with a positive nasopharyngeal reverse transcription-polymerase chain reaction (RT-PCR) test for SARS-CoV-2, a chest X-ray and blood testing at diagnosis were consecutively included.

Patients were excluded if they had a positive RT-PCR test but no chest X-ray at diagnosis, no initial laboratory testing and/or initial laboratory testing that did not include any of the five following values: leukocyte count, lymphocyte count, platelet count, lymphocyte-to-leukocyte ratio or CRP (Fig. 1 ).

All data were collected from the patients' medical records.

The primary endpoints were radiological findings on the initial chest X-ray, measurement of their extent (X-ray severity score) and correlation thereof with initial laboratory findings.

The following findings on the chest X-rays were assessed: ground-glass opacities, consolidations, linear opacities, pleural effusion, lymphadenopathy, pulmonary fibrosis due to prior lung disease, emphysema and nodules/masses. The Fleischner Society criteria for defining radiological findings were followed. 19 In cases in which ground-glass opacities or lung consolidations were present, data on their distributioncentral (in the inner two thirds of the lung), peripheral (in the outer third) or diffuse (with involvement of both)was collected. In addition, those lung fields that were affected (upper, middle or lower in each lung) and whether lesions were unilateral or bilateral were determined.

In order to grade the extent of lung involvement (X-ray severity score), each lung was divided into three fields separated by two horizontal lines: an upper line at the lower edge of the aortic arch and a lower line at the height of the pulmonary veins 13, 15 (Fig. 2 ). Extent of lung involvement was measured by adding up the score in each lung field (0 = normal and 1 = featuring involvement), yielding an overall score for both lungs of 0-6.

Regarding the initial laboratory data corresponding to the first chest X-ray, the following were collected: leukocyte count, lymphocyte count and percentage, platelet count, CRP, D-dimer, lactate dehydrogenase (LDH), ferritin and creatine kinase (CK). The time elapsed between blood testing and chest X-ray never exceeded 24 hours.

The anthropometric and demographic data that were collected were sex, age, weight and body mass index (BMI). BMI was divided into six categories: underweight (<18.5), normal weight (18.5-24.9), overweight (25-29.9), class 1 obesity (30-34.9), class 2 obesity (35-39.9) and morbid obesity (40-49.9).

The clinical data that were included were: patient origin (accident and emergency department or elsewhere), symptoms presented (fever, cough, shortness of breath, chest pain, gastrointestinal symptoms, syncope and other) and date of onset, need for admission in the first 30 days (yes or no), number of days of admission, prolonged admission (more than 30 days) and date of entering and exiting the hospital.

The dates of all the RT-PCR tests performed and the time elapsed from a positive RT-PCR test to a chest X-ray were collected.

Two second-and third-year diagnostic imaging residents (SGP and ANM, respectively) reviewed all reports corresponding to chest X-rays in systems with IMPAX 6.5.33 (Agfa-Gevaert N.V.). In cases in which no radiology report was available and uncertain cases, the residents consulted with two expert thoracic radiologists with 16 and 26 years of experience (BCM and ABGC, respectively); uncertainties were resolved by consensus.

Qualitative variables are presented with their frequency distribution. Quantitative variables are summarised with their mean and standard deviation (SD). Quantitative variables showing an asymmetrical distribution are summarised with their median and interquartile range (IQR). The distribution of continuous variables was evaluated by means of graphical inspection of histograms, box plots and Q-Q plots.

X-ray severity score was analysed as a categorical variable. For quantitative variables, means were compared using analysis of variance (ANOVA) or the Kruskall-Wallis test where quantitative variables did not have a normal distribution. The ordinal relationship between laboratory values and X-ray severity scores was evaluated using the Jonckheere-Terpstra non-parametric test. Qualitative variables were compared using the  2 test or Fisher's exact test where required. A level of significance of 5% was accepted for all tests. Data processing and analysis were performed using the SPSS Statistics V21.0 software package.

Of the total of 1,165 consecutive patients with a positive RT-PCR test for SARS-CoV-2 seen at our hospital between 29 February and 23 March 2020, 761 symptomatic adult patients comprised our study population ( Fig. 1) : 370 women and 391 men with a mean age of 65.8±17.1 years. Regarding BMI, 0.4% of patients were underweight, 14.3% were normal weight, 29.8% were overweight and 26.9% were obese. Some data required to calculate BMI were not available for 218 (28.6%) patients (Table 1 ).

In total, 97.2% of the patients went to the accident and emergency department with symptoms, 14 patients contracted COVID-19 during ward admission and seven contracted the disease during intensive care unit admission.

Fever was seen in 74.4% of the 761 patients, cough in 73.9%, shortness of breath in 44.7%, gastrointestinal symptoms in 25.4%, chest pain in 13.4% and syncope in 2%. The time elapsed between onset of symptoms and medical consultation was 0-2 days in 165 patients (21.7%), 3-5 days in 221 (29%), 6-9 days in 241 patients (31.7%) and more than 9 days in 134 (17.6%) ( Table  1) .

Of the 761 patients, 639 required hospital admission (84%) whereas 122 were discharged to isolate at home. The higher the X-ray severity score, the greater the need for admission (Table 2 ).

A total of 368 chest X-rays (48.4%) were taken with the patient standing (posteroanterior and lateral views) and 393 chest X-rays (51.6%) were taken in an anteroposterior view, of which 361 (91.8%) were portable X-rays.

Of the 761 patients studied, 295 (38.8%) had a normal chest X-ray at diagnosis and 466 (61.2%) had pathological findings. Among the pathological X-rays, 168 (36%) showed increased density in the form of ground-glass opacities, while 202 showed lung consolidation (43.3%). Ground-glass opacities and lung consolidation were seen in 40 patients (8.5%), and lobar pneumonia was seen in 56 (12%) patients. Other less common findings were pleural effusion in 25 cases (5.4%), pulmonary fibrosis due to prior disease in 15 patients (3.2%), linear opacities in nine patients (1.9%), pulmonary emphysema in another nine cases (1.9%) and pulmonary nodules or masses in four cases (0.9%). Lymphadenopathy was not identified in any patient (Table 3) .

Regarding the distribution of the chest X-ray findings, a peripheral distribution and bilateral involvement predominated: 417 cases (89.5%) showed a peripheral location; 45 cases (9.7%) showed a diffuse location, both central and peripheral; and four of 466 cases showed a central distribution (0.9%). Unilateral involvement was seen in 175 (37.6%) patients, whereas 291 had involvement in both lungs (62.4%) ( Table 3 ).

The most commonly involved lung fields were the middle and lower fields: the right middle lung field in 56.4%, the right lower lung field in 55.8%; the left middle lung field in 57.5% and the left lower lung field in 55.6%. Involvement of the right upper lung field was found in 20.4% of cases, while involvement of the left upper lung field was found in 12.2% ( Table 3) .

Of the 761 patients, 295 (38.8%) patients showed no initial involvement on X-ray (X-ray severity score 0); 141 (18.5%) patients had a score of 1; 113 (14.8%) patients had a score of 2; and 81 (10.6%) patients had a score of 3. Among the 131 remaining patients, the score was 4 for 83 (10.9%) patients, 5 for 28 patients (3.7%) and 6 for 20 patients (2.6%) ( Table 3 ).

There were no statistically significant differences in X-ray severity score either by sex or by age group; however, there were such differences by BMI (p <0.001), as BMI was higher in patients with a high X-ray severity score than in patients with a low X-ray severity score.

A statistically significant direct relationship was found between days elapsed since the onset of symptoms and X-ray severity score (p <0.001). In patients with symptoms with an onset 0-2 days earlier, no findings were encountered in 59.4% of cases; this percentage progressively decreased to 24.6% in patients with symptoms with an onset 9 or more days earlier (Fig. 3) .

Of the total of 466 X-rays with findings (61.2%), the frequency of ground-glass opacities was higher in low X-ray severity scores and decreased as those scores increased (p <0.001), whereas the opposite happened with lung consolidation, which became more common as severity scores increased (p <0.001) (Fig. 4 and Table 4 ).

The association between the laboratory values obtained (leukocytes, lymphocytes -absolute and relative values-, platelets, CRP, D-dimer, LDH, ferritin and CK) and the X-ray severity score for lung involvement on the initial chest X-ray was statistically significant in all cases. All laboratory values increased as the X-ray severity score increased, except for two, lymphocyte count and lymphocyte-to-leukocyte ratio, which decreased as involvement on X-ray increased. Statistical significance corresponded to p <0.05 for platelets, p <0.01 for lymphocytes and p <0.001 for all other values (Table 5 ).

Our study found a statistically significant relationship between the extent of involvement on the initial chest X-ray and the laboratory values studied, as well as the number of days since the onset of symptoms. The higher the X-ray severity score, the greater the need for hospital admission.

Fever and cough were the most commonly found clinical signs, followed by shortness of breath, gastrointestinal symptoms and chest pain.

In our study, 38.8% of symptomatic patients with COVID-19 had a normal chest X-ray at diagnosis and 61.2% had pathological findings; these rates were similar to those in other series, 60%-91%. 15, 20, 21 Lung involvement was predominantly bilateral, in the lower lung fields and on the lung periphery, as reported in the medical literature. 15, 18, 22 Consolidation was the most common finding, followed by ground-glass opacities, consistent with findings published in other series. 15 Lobar pneumonia was seen in 12% of our patients. This finding usually suggests a bacterial aetiology; however, these patients had a positive PCR test and were not initially diagnosed with a bacterial infection. Pleural effusion was an uncommon finding and, in nearly all cases, secondary to another disease (history of heart failure or pre-existing chronic pleural effusion on prior chest X-rays).

Various authors have proposed scoring systems for radiological findings for both CT and chest Xray in attempts to grade or measure the extent of lung involvement in patients with COVID-19 and link it to the clinical course of these patients. Warren et al. used the RALE score, which was useful for measuring the severity of adult respiratory distress syndrome. 10 Other authors have subsequently used a modified version of this scoring system to estimate the severity of lung involvement in patients with COVID-19 [14] [15] [16] 23, 24 or have created their own measurement systems, such as that of Borghesi et al., 13 who found significantly higher X-ray severity scores (p0.002) in patients who died. Moreover, Xiao et al. identified a statistically significant association between X-ray severity score and need for intubation. 25 Older patients and patients with larger numbers of comorbidities have been reported to have more severe cases of SARS-CoV-2 pneumonia. 26 Toussie et al. found that male patients, older patients and patients with higher BMIs had a higher X-ray severity scores, while Borghesi et al. observed that X-ray severity scores were significantly higher in men and patients 50-80 years of age. 11, 27 However, our study did not find any statistically significant differences between the X-ray severity score and the age or sex of our patients, but did find such differences with BMI (p <0.001).

Our study found a significant direct linear relationship between the presence of lung consolidations on chest X-ray and a higher X-ray severity score, as well as a significant inverse linear relationship between the frequency of ground-glass opacities and lower X-ray severity scores. As in the study by Toussie et al., a significant direct relationship was also seen between days elapsed since the onset of symptoms and X-ray severity score: as the number of days increased, the score worsened. 11 This was consistent with studies that have reported changes over time in pulmonary findings: groundglass opacities are the predominant pattern at the onset of symptoms, then there is progression towards a mixed pattern of ground-glass opacification and lung consolidation with peak expression from days six to 13. Finally, ground-glass opacities become predominant once again up to resolution. A percentage of patients do not follow a favourable course and show signs of pulmonary fibrosis of variable extent. 23, 28, 29 The main laboratory findings that have been linked to the severity of COVID-19 pneumonia and the clinical course of these patients are increased CRP (58.3%-60.7%), increased D-dimer (46.6%), increased LDH (41%-57%) and lymphopenia (43%-83.2%). Increased leukocytes, platelets and CK have also been reported. 12, 18, 24 In fact, Gatti et al. affirmed that LDH and CRP are the main predictors of findings on chest X-ray, with a sensitivity of 90% if both are high. 17 In our study, patients with more severe disease had more pronounced abnormalities than those with less severe disease, with a significant association seen between laboratory values obtained and X-ray severity score. All laboratory values increased as the X-ray severity score increased, except for two, lymphocyte count and lymphocyte-to-leukocyte ratio, which decreased as involvement on X-ray increased.

Our study had some limitations. First, as it was a retrospective study focused on the first part of the pandemic, we lacked both established protocols for radiology reports in patients with COVID-19 and definitive knowledge of which values were most useful in blood testing; consequently, there were substantial amounts of missing data, ultimately limiting the final sample size. However, the time elapsed between the chest X-ray and the blood testing at diagnosis was always less than 24 hours. Second, our study had the limitations inherent to the radiology technique used in execution and interpretation, in many cases magnified by the clinical condition of these patients.

In conclusion, chest X-ray is a valid technique in the initial assessment of patients with COVID-19, and its findings should be taken into account along with laboratory and clinical data when evaluating the clinical course of these patients, as a higher X-ray severity score is associated with a higher incidence of hospital admission and more abnormal laboratory values. pacientes restantes, 119 no presentaban las detecciones analíticas en sangre de los 5 parámetros necesarios para la inclusión en este estudio: recuento de leucocitos, de linfocitos, de plaquetas, cociente linfocitos/leucocitos y PCR.

Radiografía de tórax con la división pulmonar en seis campos que se ha empleado en nuestro estudio para la valoración de la distribución de los hallazgos radiológicos. La línea horizontal superior pasa por el borde inferior del arco aórtico y la línea horizontal inferior pasa a la altura de las venas pulmonares inferiores. A y B) Campos superiores. C y D) Campos medios.

J o u r n a l P r e -p r o o f Figura 3 Relación porcentual entre los días transcurridos desde el inicio de los síntomas y el índice de gravedad radiográfico. En el eje x están representados cada uno de los índices de gravedad radiológicos (se combinaron los índices de gravedad 5 y 6 por el escaso número de pacientes). En el eje y está representado el porcentaje de pacientes con un determinado tiempo de evolución de los síntomas dentro de cada índice de gravedad. periférica, en el campo medio derecho (score = 1) (flecha). El paciente ingresó y en la radiografía de tórax del día 24 de marzo de 2020 se ve un claro empeoramiento radiológico con consolidaciones pulmonares bilaterales, más extensas (flechas), asociado a un incremento de las necesidades de oxigenoterapia. C y D) Mujer de 33 años, procedente de Guatemala, sin antecedentes personales de interés, que acude al servicio de urgencias derivada por su médico de atención primaria por tos y fiebre de 9 días de evolución. Analítica sanguínea: leucocitos 5100/μL, linfocitos 1400/μL (linfocitos/leucocitos 27,9%), plaquetas 224 000/μL, PCR 8,44 mg/dL, dímero D 500 ng/mL y LDH 666 U/L. En la radiografía de tórax posteroanterior del 17 de marzo de 2020 se identifican consolidaciones pulmonares bilaterales, parcheadas y de predominio en los lóbulos inferiores (score = 5) (flechas). La paciente ingresó y 2 días después presentó empeoramiento clínico y analítico, observándose en la radiografía del día 23 de marzo un empeoramiento radiológico, con confluencia de las consolidaciones previas. Figure 2 Chest X-ray with lung division into six fields used in our study to assess distribution of Xray findings. The upper horizontal line is at the lower edge of the aortic arch and the lower horizontal line is at the height of the inferior pulmonary veins. A and B) Upper fields. C and D) Middle fields. E and F) Lower fields. 5+6 Índice de gravedad radiográfico X-ray severity score 0-2 0-2 3-5 3-5 6-9 6-9 >9 >9 Figure 3 Percentage relationship between days elapsed since the onset of symptoms and X-ray severity score. The x-axis represents each X-ray severity score (scores 5 and 6 were combined due to limited numbers of patients). The y-axis represents the percentage of patients with a particular time since the onset of symptoms within each severity score. gr3 Figure 4 A and B) A 49-year-old man, a former smoker who quit smoking five years earlier, had a history of hypertension, dyslipidaemia, hypertensive cardiomyopathy, hyperuricaemia, kidney transplantation and total thyroidectomy due to papillary thyroid carcinoma. He came in with fever, dry cough and muscle pain for the past four days. Laboratory data: leukocytes 7,100/l, lymphocytes 600/l (lymphocyte-to-leukocyte ratio 7.7%), platelets 140,000/l, CRP 1.63 mg/dl, D-dimer 754 ng/ml and LDH 471 U/l. A posteroanterior chest X-ray taken on 16 March 2020 showed a peripheral ground-glass opacity in the right middle field (X-ray severity score = 1) (arrow). The patient was admitted, and a chest X-ray taken on 24 March 2020 showed clear radiological worsening with more extensive bilateral lung consolidations (arrows) associated with an increased need for oxygen therapy. C and D) A 33-year-old woman from Guatemala with no personal history of note visited the accident and emergency department with a referral from her primary care doctor due to cough and fever for the past nine days. Blood testing: leukocytes 5,100/l, lymphocytes 1,400/l (lymphocyte-to-leukocyte ratio 27.9%), platelets 224,000/l, CRP 8.44 mg/dl, D-dimer 500 ng/ml and LDH 666 U/l. A posteroanterior chest X-ray taken on 17 March 2020 identified patchy bilateral lung consolidations predominantly in the lower lobes (score = 5) (arrows). The patient was admitted, and two days later, she showed worsening of signs and symptoms as well as laboratory values; a chest X-ray taken on 23 March showed radiological worsening, with confluence of her prior consolidations. gr4 J o u r n a l P r e -p r o o f 5+6 a 48 (100%) 0 (0%) a Due to the limited number of patients with a high severity score, a decision was made to combine severity scores of 5 and 6 into a single category. 

Responsible for study integrity: AB, BC

Data analysis and interpretation: MEFF

Statistical processing: MEFF

Literature search: AB

Critical review of the manuscript with intellectually significant contributions: AB, BC. 10. Approval of the final version

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19

Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features

COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression

Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome

Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19

Diagnostic and Prognostic Value of Chest Radiographs for COVID-19 at Presentation

Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Fleischner Society: Glossary of Terms for Thoracic Imaging

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea

Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review

CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Chest radiograph at admission predicts early intubation among inpatient COVID-19 patients

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients

Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms

CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients

The authors declare that they have no conflicts of interest. 5+6  38  10  9  39  Total 258  208  224 242 Due to the limited number of patients with a high severity score, a decision was made to combine severity scores of 5 and 6 into a single category.